Form 4: National Healthcare Corp: Officer Vicki L. Dodson Reports Stock Transactions
SEC Form 4
Vicki L. Dodson, a Senior VP at National Healthcare Corp, reports the withholding of shares to cover tax obligations following the vesting of restricted stock.
Summary
- On January 1, 2025, Vicki L. Dodson, Senior VP at National Healthcare Corp (NHC), reported transactions related to the company's common stock.
- Specifically, 361 shares were withheld to cover tax obligations after the vesting of restricted stock.
- The vesting related to grants made on February 25, 2022, March 8, 2023, and March 5, 2024.
- Following the reported transaction, Dodson directly owns 6,600.5455 shares of NHC common stock.
- Dodson also holds options to purchase 3,734 shares (exercisable 02/18/2023, expiring 02/18/2027), 7,467 shares (exercisable 03/08/2024, expiring 03/08/2028), and 12,000 shares (exercisable 03/05/2025, expiring 03/05/2029).
Sentiment
Score: 5
Explanation: This is a neutral informational filing. It doesn't indicate positive or negative sentiment, but rather reports required transactions.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding insider transactions.
Comparison to Industry Standards
- Executive compensation packages including stock options and restricted stock units are standard practice across the healthcare industry.
- Companies like Brookdale Senior Living and Life Care Centers of America also utilize similar equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and option terms are generally comparable to industry norms, designed to incentivize long-term performance.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it primarily reflects internal compensation adjustments.
- Employees may be indirectly affected through the overall compensation structure and its impact on company performance.
Key Dates
| Date | Description |
|---|---|
| 02/25/2022 | Original grant date of restricted stock (partially vested on 01/01/2025) |
| 02/18/2023 | Date option to purchase 3,734 shares became exercisable |
| 03/08/2023 | Original grant date of restricted stock (partially vested on 01/01/2025) |
| 03/08/2024 | Date option to purchase 7,467 shares became exercisable |
| 03/05/2024 | Original grant date of restricted stock (partially vested on 01/01/2025) |
| 01/01/2025 | Date of stock transaction: withholding of shares for tax obligations after vesting of restricted stock |
| 03/05/2025 | Date option to purchase 12,000 shares becomes exercisable |
| 02/18/2027 | Expiration date for option to purchase 3,734 shares |
| 03/08/2028 | Expiration date for option to purchase 7,467 shares |
| 03/05/2029 | Expiration date for option to purchase 12,000 shares |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.